ClinicalTrials.Veeva

Menu

Chromoendoscopy for Ulcerative Colitis Surveillance

I

Indiana University School of Medicine

Status

Completed

Conditions

Ulcerative Colitis
Crohn's Disease

Treatments

Procedure: Chromoendoscopy with magnification

Study type

Observational

Funder types

Other

Identifiers

NCT00274209
0509-71

Details and patient eligibility

About

Long-standing ulcerative colitis is associated with an increased cancer risk. Chromoendoscopy with dye spraying can detect subtle abnormalities that are not visible with standard endoscopy. The purpose of this study is to determine if chromoendoscopy with fewer "targeted biopsies" can replace standard colonoscopy with multiple "random" biopsies.

Full description

Patients with ulcerative colitis (UC) are at increased risk for colon cancer. Current guidelines recommend periodic surveillance colonoscopy in individuals who fulfill certain high-risk criteria. Endoscopists must perform a high number of biopsies (over 33 per patient) in order to increase the yield of such procedures. Chromoendoscopy (CE) has the ability to identify subtle lesions that are otherwise missed by standard endoscopy. Whether CE can replace standard colonoscopy in the surveillance of patients with UC is unknown.

Comparison: both standard biopsies and targeted biopsies will be obtained during colonoscopy from patients with UC who are candidates for surveillance colonoscopy. The yield of the two methods will be compared based on the number of biopsies required to identify one dysplastic (precancerous) lesion.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ulcerative colitis, pancolitis > 8 years; left-sided > 15 years or
  • history of PSC or
  • history of previous dysplasia on colon biopsies or
  • family history of colon cancer in first degree relative

Exclusion criteria

  • any condition that precludes colonoscopy
  • expected survival less than 1 year

Trial design

100 participants in 1 patient group

IBD patients at risk for neoplasia
Description:
Patients with long-standing ulcerative colitis or Crohn's colitis at risk for neoplasia.
Treatment:
Procedure: Chromoendoscopy with magnification

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems